Evaluation Studies Sample Clauses

Evaluation Studies. 25 CONTRACTOR shall participate as requested by COUNTY in research 26 and/or evaluative studies designed to show the effectiveness and/or efficiency 27 of CONTRACTOR’s services or provide information about CONTRACTOR’s project. 28 ///
AutoNDA by SimpleDocs
Evaluation Studies. CONTRACTOR shall participate, as requested by COUNTY, in research and/or evaluative studies designed to show the effectiveness and/or efficiency of CONTRACTOR’s services or provide information about CONTRACTOR’s project.
Evaluation Studies. Contractor shall participate as requested by the County in research and/or evaluative studies designed to show the effectiveness and/or efficiency of Contractor services or to provide information about Contractor's project.
Evaluation Studies. 19 CONTRACTOR shall participate as requested by COUNTY in research 20 and/or evaluative studies designed to show the effectiveness and/or efficiency 21 of CONTRACTOR’s services or provide information about CONTRACTOR’s project.
Evaluation Studies. 3 CONTRACTOR shall participate as requested by COUNTY in research 4 and/or evaluative studies designed to show the effectiveness and/or efficiency 5 of CONTRACTOR’s services or provide information about CONTRACTOR’s project.
Evaluation Studies. 5 CONTRACTOR shall participate as requested by COUNTY in research 6 and/or evaluative studies designed to show the effectiveness and/or efficiency 7 of CONTRACTOR’s services or provide information about CONTRACTOR’s project.
Evaluation Studies. 9 CONTRACTOR shall participate as requested by COUNTY in research and/or 10 evaluative studies designed to show the effectiveness and/or efficiency of 11 CONTRACTOR’s services or provide information about CONTRACTOR’s project.
AutoNDA by SimpleDocs
Evaluation Studies. As requested by COMMISSION and State Commission (CCFC), CONTRACTOR shall participate in research and evaluation studies designed to show the effectiveness of CONTRACTOR services or to provide information about CONTRACTOR's Program.
Evaluation Studies 

Related to Evaluation Studies

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Trials The Ship shall run the following test and trials:

  • Evaluation Criteria 5.2.1. The responses will be evaluated based on the following: (edit evaluation criteria below as appropriate for your project)

Time is Money Join Law Insider Premium to draft better contracts faster.